BioDelivery Sciences International, Inc.

BioDelivery Sciences (“BDSI”®) is a specialty pharmaceutical company with a focus in the areas of pain management and addiction medicine. We are utilizing our novel and proprietary BioErodible MucoAdhesive (BEMA®) and other drug delivery technologies to develop and commercialize, either on our own or in partnership with third parties, new applications of proven therapies aimed at addressing important unmet medical needs

Bank Name BioDelivery Sciences International, Inc.
Stock Exchange NASDAQ
Symbol BDSI
Sector Healthcare
Industry Major Pharmaceuticals
Country United States
World Region America
Chairman
CEO Mr. Herm Cukier
Employees 115
Website www.bdsi.com
Registered Year 1997

UpdateContent
UpdateContent
UpdateContent